Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · IEX Real-Time Price · USD
1.960
-0.160 (-7.55%)
At close: Jul 2, 2024, 4:00 PM
1.980
+0.020 (1.02%)
After-hours: Jul 2, 2024, 7:31 PM EDT
Immix Biopharma Market Cap
Immix Biopharma has a market cap or net worth of $51.77 million as of July 2, 2024. Its market cap has increased by 41.84% in one year.
Market Cap
51.77M
Enterprise Value
23.55M
1-Year Change
41.84%
Ranking
Category
Stock Price
$1.96
Market Cap Chart
Since the IPO on December 16, 2021, Immix Biopharma's market cap has decreased from $65.74M to $51.77M, a decrease of -21.25%. That is a compound annual growth rate of -8.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 51.80M | -62.33% |
| Dec 29, 2023 | 137.50M | 331.03% |
| Dec 30, 2022 | 31.90M | 24.61% |
| Dec 31, 2021 | 25.60M | -61.06% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cidara Therapeutics | 54.47M |
| Neuronetics | 54.00M |
| Rockwell Medical | 53.36M |
| Mural Oncology | 53.14M |
| Milestone Scientific | 52.77M |
| Modular Medical | 51.41M |
| LENSAR | 51.29M |
| Reneo Pharmaceuticals | 50.47M |